<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>12</Volume><Issue>9</Issue><PubDate PubStatus="epublish"><Year>2021</Year><Month>10</Month><Day>20</Day></PubDate></Journal><title locale="en_US">The Effects of Smoking on Metabolic Syndrome and Its Components  Using Causal Methods in the Iranian Population</title><FirstPage>2530</FirstPage><LastPage>2530</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Epidemiology  and Biostatistics, School of  Public Health, Tehran University  of Medical Sciences, Tehran</affiliation></Author><Author><affiliation locale="en_US">Osteoporosis Research Center,  Endocrinology and Metabolism  Clinical Sciences Institute, Tehran  University of Medical Sciences,</affiliation></Author><Author><affiliation locale="en_US">Department of Endocrinology,  AJA University of Medical  Sciences, Tehran</affiliation></Author><Author><affiliation locale="en_US">Department of Epidemiology  and Biostatistics, School of  Public Health, Tehran University  of Medical Sciences, Tehran</affiliation></Author><Author><affiliation locale="en_US">Prevention of  Metabolic Disorders Research  Center &amp; Department of Biostatistics  and Epidemiology, Research  Institute for Endocrine Sciences,  Shahid Beheshti University of  Medical Sciences, Tehran</affiliation></Author><Author><affiliation locale="en_US">Department of Epidemiology  and Biostatistics, School of  Public Health, Tehran University  of Medical Sciences, Tehran</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>20</Day></PubDate></History><abstract locale="en_US">Background: The aim of this study was to estimate the effect of smoking on metabolic syndrome (MS) and its components applying inverse probability‑of‑treatment weighting (IPTW) and propensity score (PS) matching. Methods: Using data from Tehran Lipid and Glucose Study, 4857 participants aged over 20 years with information on smoking and confounders in the third phase (2005–2008) were included, and the MS was assessed in the fifth phase (2011–2014). IPTW and PS matching were used to adjust for confounders. Results: Based on average treatment effect (ATE) estimates, smoking decreased the risk of hypertension (RR: 0.62; 95% CI: 0.43, 0.88), but increased the risk of low HDL cholesterol (1.20; 0.98, 1.48). Similarly, the average treatment effect in the treated (ATT) estimates using IPTW and PS matching suggested that smoking decreased the risk of hypertension (0.63; 0.52, 0.76, and 0.68; 0.54, 0.85), and increased the risk of low HDL cholesterol (1.24; 1.07, 1.43, and 1.28; 1.06, 1.54), respectively. Conclusions: Smoking seems to increase the risk of low HDL cholesterol but decreases the risk of hypertension.</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2530</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2530/717718370</pdf_url></Article></Articles>
